HA
STJ

Havens Advisors’s St Jude Medical STJ Stock Holding History

Havens Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-199,700
Closed -$16M – 45
2016
Q4 		$16M Buy
199,700
+52,300
+35% +$4.15M 10.69% 1
2016
Q3 		$11.8M Buy
147,400
+51,200
+53% +$4.13M 9.16% 2
2016
Q2 		$7.5M Buy
+96,200
New +$6.86M 5.7% 4

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Havens Advisors's STJ Position: Q1 2017 in Review

Havens Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 199,700 shares — an estimated $16M sold.

Havens Advisors first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $16M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Havens Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Havens Advisors sold 199,700 St Jude Medical shares in Q1 2017, an estimated $16M.
  • Havens Advisors first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Havens Advisors's St Jude Medical position peaked at $16M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Havens Advisors's 13F filing for Q1 2017, filed 24 Apr 2017.